US › Healthcare

Alcon AG (ALC)

US · Healthcare · Medical Instruments & Supplies

$65.18-1.69%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$2.82B

Revenue YoY

+8.7%

Net profit

Profit YoY

-100.0%

EPS

$0.84

EPS estimate

$0.77

Net margin

0.0%

EPS came in at 0.84 against a street estimate of 0.77 — a beat of 9.1%.

Key statistics

Market cap

$32.17B

P/E

52.4

Forward P/E

16.8

P/B

1.53

Book value

$44.67

EPS (TTM)

$1.27

Dividend yield

0.53%

52-week high

$87.22

52-week low

$61.84

50-day MA

$70.41

200-day MA

$74.39

Beta

0.70

Analyst view

Analysts rate Alcon AG a buy (21 buy, 6 hold, 0 sell out of 27) with an average price target of $85.24.

Shareholding

Insiders

0.20%

Institutions

63.76%

Largest institutional holders

Fund	Stake
Bank of New York Mellon Corp	3.24%
Vanguard Capital Management, LLC	3.08%
FMR Inc	2.57%
NORGES BANK	2.27%
Aristotle Capital Management LLC	2.01%
Ako Capital Llp	2.00%
Zurcher Kantonalbank	1.64%
UBS Group AG	1.23%

Corporate actions

Action	Detail	Date
Dividend	$0.36 / share ex-date May 6, 2026 · pay May 7, 2026	2026-05-06

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alcon AG — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.